FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server  |   User: [n/a]

All Loinc Codes

  • 1-8: Acyclovir [Susceptibility]
  • 10-9: Amdinocillin [Susceptibility] by Serum bactericidal titer
  • 100-8: Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
  • 1000-9: DBG Ab [Presence] in Serum or Plasma from Blood product unit
  • 10000-8: R wave duration in lead AVR
  • 100002-5: Specimen care is maintained
  • 100003-3: Team communication is maintained throughout care
  • 100004-1: Demonstrates knowledge of the expected psychosocial responses to the procedure
  • 100005-8: Demonstrates knowledge of nutritional management related to the procedure
  • 100006-6: Demonstrates knowledge of medication management
  • 100007-4: Demonstrates knowledge of pain management
  • 100008-2: Demonstrates knowledge of wound management
  • 100009-0: Demonstrates knowledge of the procedure and expected results
  • 10001-6: R wave duration in lead I
  • 100010-8: No injury related to procedure equipment, medical supplies, or instrumentation
  • 100011-6: No injury related to an electrical source
  • 100012-4: Participates in decisions affecting the patient's plan of care
  • 100013-2: Participates in the discharge process
  • 100014-0: Psychosocial health is maintained at or improved from baseline
  • 100015-7: No injury related to positioning due to care or procedure
  • 100016-5: No injury related to a laser source
  • 100017-3: Perioperative nursing data set outcomes panel [PNDS]
  • 100018-1: Hospice care Note
  • 100019-9: ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 10002-4: R wave duration in lead II
  • 100020-7: GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100021-5: GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100022-3: IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100023-1: IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100024-9: SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100025-6: SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100026-4: MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100027-2: Gen SMAD4 Analisis de mutaciones
  • 100028-0: FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  • 100029-8: Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
  • 10003-2: R wave duration in lead III
  • 100030-6: Axis I: Temporal aspects score [Mainz Pain Staging System]
  • 100031-4: Axis II: Spatial aspects score [Mainz Pain Staging System]
  • 100032-2: Axis III: Drug taking behavior score [Mainz Pain Staging System]
  • 100033-0: Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
  • 100034-8: Provider of automated external defibrillator use
  • 100035-5: Exam finding location of Chest
  • 100036-3: Exam finding location of Lung
  • 100037-1: Patient contact disposition EMS unit
  • 100038-9: Patient evaluation disposition EMS unit
  • 100039-7: Crew disposition for patient care EMS unit
  • 10004-0: R wave duration in lead V1
  • 100040-5: Patient transport disposition EMS unit
  • 100041-3: Aminoglucósido
  • 100042-1: Atovacuona
  • 100043-9: Azitromicina+Etambutol

Page 1 of 1966 Next End


LOINC Home